✦ LIBER ✦

Ritonavir-Boosted Protease Inhibitors: Impact of Ritonavir on Toxicities in Treatment-Experienced Patients

✍ Scribed by Michael Sension; Peter J. Piliero

Book ID: 116609522
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 137 KB
Volume: 18
Category: Article
ISSN: 1055-3290
DOI: 10.1016/j.jana.2006.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relative antiviral efficacy of ritonavir

Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials

✍ A Hill; G Moyle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Abacavir/Lamivudine Versus Tenofovir/Emt

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir

✍ Martínez, Esteban; d'Albuquerque, Polyana M.; Pérez, Ignacio; Pich, Judit; Gatel 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 294 KB

Resistance profiles observed in virologi

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

✍ Anne-Geneviève Marcelin; Dissou Affolabi; Claire Lamotte; Hocine Ait Mohand; Con 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Amprenavir (APV) is an HIV protease inhibitor (PI) used for the treatment of either naive or PI‐experienced HIV‐infected patients. Several genotypic resistance pathways in protease gene have been described to be associated to unboosted APV failure (I50V, V32I + I47V, I54L/M, or less com

Long-term treatment outcomes of ritonavi

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure

✍ Weerawat Manosuthi; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somn 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 139 KB

Impact of nevirapine or efavirenz co-adm

Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients

✍ Eric Dailly; François Raffi; Charlotte Biron; C. Allavena; P. Jolliet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Efficacy and tolerability of a double bo

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

✍ P Chetchotisakd; S Anunnatsiri; P Mootsikapun; S Kiertiburanakul; T Anekthananon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB